https://www.marketscreener.com/quote/stock/ENTASIS-THERAPEUTICS-HOLD-46353304/news/Entasis-Therapeutics-Holdings-Inc-Presents-Data-Highlights-from-Phase-3-Attack-Trial-At-2022-Americ-40465131/?utm_source=telegram&utm_medium=social&utm_campaign=share